BKK:VIH-R (Thailand)
Â
Units Non-Voting Depository Receipts
฿
8.95
(0%)
Jun 25
Business Description
Srivichaivejvivat PCL
Share Class Description:
BKK:VIH-R: Units Non-Voting Depository ReceiptsCompare
Compare
Traded in other countries / regions
VIH.Thailand IPO Date
2012-05-09Description
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 22 |
N/A
|
N/A
| |||
Equity-to-Asset | 0.86 |
N/A
|
N/A
| |||
Debt-to-Equity | 0.02 |
N/A
|
N/A
| |||
Debt-to-EBITDA | 0.09 |
N/A
|
N/A
| |||
Interest Coverage | 133.29 |
N/A
|
N/A
| |||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.23 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.7 | |||||
3-Year EBITDA Growth Rate | -13.2 |
N/A
|
N/A
| |||
3-Year EPS without NRI Growth Rate | -16.5 |
N/A
|
N/A
| |||
3-Year FCF Growth Rate | -3.8 |
N/A
|
N/A
| |||
3-Year Book Growth Rate | 6.6 |
N/A
|
N/A
|
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.21 |
N/A
|
N/A
| |||
9-Day RSI | 43.96 |
N/A
|
N/A
| |||
14-Day RSI | 51.69 |
N/A
|
N/A
| |||
3-1 Month Momentum % | -0.57 |
N/A
|
N/A
| |||
6-1 Month Momentum % | 19.16 |
N/A
|
N/A
| |||
12-1 Month Momentum % | 25.11 |
N/A
|
N/A
|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.73 |
N/A
|
N/A
| |||
Quick Ratio | 4.57 |
N/A
|
N/A
| |||
Cash Ratio | 3.21 |
N/A
|
N/A
| |||
Days Inventory | 9.47 |
N/A
|
N/A
| |||
Days Sales Outstanding | 42.95 |
N/A
|
N/A
| |||
Days Payable | 57.51 |
N/A
|
N/A
|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.47 |
N/A
|
N/A
| |||
Dividend Payout Ratio | 0.56 |
N/A
|
N/A
| |||
3-Year Dividend Growth Rate | -20.6 |
N/A
|
N/A
| |||
Forward Dividend Yield % | 4.47 |
N/A
|
N/A
| |||
5-Year Yield-on-Cost % | 8.16 |
N/A
|
N/A
| |||
3-Year Average Share Buyback Ratio | -2.2 |
N/A
|
N/A
| |||
Shareholder Yield % | 5.07 |
N/A
|
N/A
|
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.62 |
N/A
|
N/A
| |||
Operating Margin % | 17.65 |
N/A
|
N/A
| |||
Net Margin % | 14.09 |
N/A
|
N/A
| |||
EBITDA Margin % | 23.88 |
N/A
|
N/A
| |||
FCF Margin % | 12.1 |
N/A
|
N/A
| |||
OCF Margin % | 17.86 |
N/A
|
N/A
| |||
ROE % | 11.68 |
N/A
|
N/A
| |||
ROA % | 10.07 |
N/A
|
N/A
| |||
ROIC % | 16.74 |
N/A
|
N/A
| |||
3-Year ROIIC % | -61.1 |
N/A
|
N/A
| |||
ROC (Joel Greenblatt) % | 23.8 |
N/A
|
N/A
| |||
ROCE % | 14.15 |
N/A
|
N/A
| |||
Years of Profitability over Past 10-Year | 10 |
N/A
|
N/A
|
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 11.26 |
N/A
|
N/A
| |||
Forward PE Ratio | 15.98 |
N/A
|
N/A
| |||
PE Ratio without NRI | 11.34 |
N/A
|
N/A
| |||
Price-to-Owner-Earnings | 18.63 |
N/A
|
N/A
| |||
PS Ratio | 1.59 |
N/A
|
N/A
| |||
PB Ratio | 1.25 |
N/A
|
N/A
| |||
Price-to-Tangible-Book | 1.25 |
N/A
|
N/A
| |||
Price-to-Free-Cash-Flow | 13.13 |
N/A
|
N/A
| |||
Price-to-Operating-Cash-Flow | 8.9 |
N/A
|
N/A
| |||
EV-to-EBIT | 6.72 |
N/A
|
N/A
| |||
EV-to-EBITDA | 5.01 |
N/A
|
N/A
| |||
EV-to-Forward-EBITDA | 4.34 |
N/A
|
N/A
| |||
EV-to-Revenue | 1.2 |
N/A
|
N/A
| |||
EV-to-Forward-Revenue | 1.08 |
N/A
|
N/A
| |||
EV-to-FCF | 9.47 |
N/A
|
N/A
| |||
Price-to-GF-Value | 0.96 |
N/A
|
N/A
| |||
Price-to-Projected-FCF | 0.71 |
N/A
|
N/A
| |||
Price-to-Median-PS-Value | 0.96 |
N/A
|
N/A
| |||
Price-to-Graham-Number | 0.79 |
N/A
|
N/A
| |||
| Price-to-Net-Current-Asset-Value | 3.13 |
N/A
|
N/A
| |||
| Price-to-Net-Cash | 5.66 |
N/A
|
N/A
| |||
Earnings Yield (Greenblatt) % | 14.88 |
N/A
|
N/A
| |||
FCF Yield % | 7.32 |
N/A
|
N/A
| |||
Forward Rate of Return (Yacktman) % | -4.84 |
N/A
|
N/A
|
Srivichaivejvivat PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Srivichaivejvivat PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.400000 Cash Dividend | 2026-03-13 | 9.20 (+0.00%) | ||
| THB 0.250000 Cash Dividend | 2025-03-13 | 7.29 (+0.00%) | ||
| 1.06667:1 Stock Split | 2014-10-24 | -- |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Srivichaivejvivat PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers